company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2951000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2951000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2951000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2591000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7256000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,658000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1732000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12237000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9286000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,334000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,95000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-239000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9525000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9525000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9525000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9525000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31815000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31815000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31800000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 14:20:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2408000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2408000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2408000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2421000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7215000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,483000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1218000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-50000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11287000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8879000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,332000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,124000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-208000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9087000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9087000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9087000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9087000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31922000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31922000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32500000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 12:48:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2516000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2516000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2516000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2336000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6853000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,483000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2502000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12174000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9658000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,485000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,84000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-401000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10059000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10059000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10059000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10059000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32047000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.31
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32047000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.31
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32400000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.31
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1952000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1952000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1952000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2240000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7169000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,483000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1941000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11833000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9881000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,434000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,79000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-355000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10236000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10236000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10236000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10236000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37900000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37900000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37463000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:01:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2363000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2363000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2363000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2273000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8594000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,656000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2318000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13841000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11478000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,438000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,144000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-294000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11772000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11772000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11772000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11772000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43600000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43600000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44136000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 08:14:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2434000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2434000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2434000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2344000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9823000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,291000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2358000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14816000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12382000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,439000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,396000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-307000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-350000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12732000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12732000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12732000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12732000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39600000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39600000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39501000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2433000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2433000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2433000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2317000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10769000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,291000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2344000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15721000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13288000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,433000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,205000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-228000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13516000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13516000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13516000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13516000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50100000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50100000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50145000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2009000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2009000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2009000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2219000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11114000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,291000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1873000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15497000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13488000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,411000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,126000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-285000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13773000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13773000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13773000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13773000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59900000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59900000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58733000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 10:03:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3113000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3113000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3113000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2835000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11769000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,254000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3006000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17864000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14751000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,381000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,105000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-276000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15027000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15027000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15027000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15027000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60100000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60100000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59467000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 09:47:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3647000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3647000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3647000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2645000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13746000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,254000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3552000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20197000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16550000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,351000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,94000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-257000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16807000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16807000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16807000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16807000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58000000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58000000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57713000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2414000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2414000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2414000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3138000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14090000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,253000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2334000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19815000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17401000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,310000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,379000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,69000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17332000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17332000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17332000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17332000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75400000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75400000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74027000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,97000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,97000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,97000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3411000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15090000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,254000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18755000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18658000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,519000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,161000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-358000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19016000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19016000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19016000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19016000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,79200000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,79200000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,80899000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 09:01:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,980000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,980000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,980000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3578000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20417000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,254000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24249000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23269000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,142000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,129000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23140000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23140000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23140000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23140000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,79800000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,79800000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,81015000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 09:09:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,620000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,620000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,620000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4678000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17804000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,252000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22734000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22114000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,85000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,137000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,52000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22062000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22062000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22062000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22062000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,80000000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,80000000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,79777000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,416000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,416000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,416000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4582000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27070000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,253000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31905000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31489000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1586000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1586000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29903000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29903000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29903000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29903000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90600000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90600000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,89270000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,592000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,592000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,592000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4787000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24100000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,254000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29141000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28549000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,275000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,275000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28274000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28274000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28274000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28274000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,88400000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,88400000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,89361000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:10:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1101000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1101000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1101000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5004000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26185000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,254000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31443000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30342000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2260000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2260000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28082000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28082000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28082000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28082000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90600000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.31
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90600000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.31
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,89404000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:01:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.31
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1477000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1477000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1477000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6249000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27026000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,252000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33527000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32050000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,229000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,229000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31821000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31821000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31821000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31821000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,89500000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,89500000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,89399000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,486000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,486000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,486000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6089000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25125000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,253000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31467000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30981000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,807000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,807000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30174000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30174000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30174000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30174000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,91400000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,91400000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,92437000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2178000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2178000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2178000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8184000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26490000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,254000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34928000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32750000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,391000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,391000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32359000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32359000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32359000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32359000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,98100000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,98100000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98482000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 16:11:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1026000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1026000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1026000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8487000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24656000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,254000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33397000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32371000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,391000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,391000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31980000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31980000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31980000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31980000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99900000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99900000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98568000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:16:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1790000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1790000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1790000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11077000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23900000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,252000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35229000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33439000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,755000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,755000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32684000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32684000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32684000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32684000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97100000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,97100000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,97051000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1303000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1303000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1303000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9307000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27447000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,253000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37007000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35704000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1031000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1031000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34673000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34673000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34673000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34673000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99100000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99100000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98689000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1389000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1389000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1389000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7790000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25711000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,254000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33755000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32366000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,414000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,414000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31952000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31952000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31952000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31952000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99900000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99900000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98817000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:06:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2220000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2220000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2220000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6950000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25009000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,254000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32213000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29993000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,395000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,395000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29598000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29598000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29598000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29598000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102100000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102100000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100672000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 08:22:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1874000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1874000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1874000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11932000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24559000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,236000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36727000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34853000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2546000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2546000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32307000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32307000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32307000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32307000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6800000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.75
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6800000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.75
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6769000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.75
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1534000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1534000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1534000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7229000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25793000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,224000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3400000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36646000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35112000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,851000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,851000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34261000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34261000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34261000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34261000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,122400000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,122400000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,122648000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3829000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3829000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3829000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6534000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24999000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,224000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1000000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32757000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28928000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,362000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,362000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28566000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28566000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28566000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28566000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,124200000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,124200000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,125202000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:06:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3924000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3924000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3924000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5346000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21915000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,224000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,13000000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-4600000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35885000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31961000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,398000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,398000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31563000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5200000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26363000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26363000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26363000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,131800000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,131800000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,129640000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:07:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3456000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3456000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3456000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5894000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23464000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,224000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-800000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,200000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28982000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25526000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2603000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2603000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22923000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-19082000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3841000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3841000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3841000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8600000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8600000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8570000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4068000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4068000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4068000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5593000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21875000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,224000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-13600000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,109653000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,123745000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-119677000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,780000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,780000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-118897000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-765000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-118132000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-118132000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-118132000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9400000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-12.61
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9400000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-12.61
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,9370000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-12.61
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2763000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2763000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2763000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5621000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21448000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-7433000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19636000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16873000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,466000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,466000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16407000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16407000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16407000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16407000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9800000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.67
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9800000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.67
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,9829000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:06:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.67
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,941000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,941000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,941000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3722000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11918000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-6935000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8705000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7764000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,521000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,521000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7243000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7243000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7243000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7243000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,11000000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.66
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11000000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.66
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10912000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 09:01:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.66
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1766000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1766000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1766000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4333000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11208000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1653000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13888000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12122000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2720000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2720000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9402000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9402000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9402000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9402000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10400000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.9
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10400000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.9
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10442000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.9
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1425000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1425000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1425000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4896000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11151000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1519000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1800000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19366000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17941000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,702000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,702000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17239000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17239000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17239000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17239000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12300000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.4
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,12300000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.4
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12297000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.4
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,715000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,715000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,715000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3908000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10081000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1017000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12972000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12257000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,478000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,478000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11779000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11779000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11779000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11779000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14000000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.84
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14000000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.84
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13952000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:06:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.84
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,546000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,546000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,546000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3403000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11101000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2114000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12390000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11844000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,431000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,431000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11413000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11413000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11413000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11413000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15200000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.75
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15200000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.75
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15282000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 09:01:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.75
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,887000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,887000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,887000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3219000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10339000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,318000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13876000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12989000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2542000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2542000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10447000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10447000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10447000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10447000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14500000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.72
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14500000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.72
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14507000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.72
